Kevin Harrington, Professor in Biological Cancer Therapies at Institute of Cancer Research, shared a post on LinkedIn:
“I recently had the opportunity to work with my friend Professor Christophe Le Tourneau to discuss recent developments in the management of patients with head and neck squamous cell cancers.
We discussed new approaches in both newly-diagnosed, locally-advanced disease and recurrent/metastatic head and neck cancer.
As ever, it was a great pleasure to interact with Christophe. I hope that people will find the opportunity to tune into our discussions.”
More posts featuring Kevin Harrington on OncoDaily.